Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021

SELL
$14.15 - $17.19 $14,150 - $17,190
-1,000 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$14.14 - $19.71 $14,140 - $19,710
1,000 New
1,000 $14,000
Q1 2020

May 08, 2020

SELL
$14.38 - $27.72 $14,380 - $27,720
-1,000 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$9.23 - $19.67 $9,230 - $19,670
1,000 New
1,000 $19,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $69.4M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.